Blockchain Registration Transaction Record

ioTech International Releases ioRinse™ MR for Cancer Patients

ioTech International announces the release of ioRinse™ MR, an advanced oral rinse developed specifically to provide substantial relief for cancer patients suffering from mouth sores, dry mouth, oral pain, and ulcers. Leveraging ioTech’s proprietary molecular iodine technology, ioRinse™ MR offers immediate, lasting relief without causing tooth staining.

This news matters as it introduces a product that can provide substantial relief for cancer patients suffering from debilitating side effects of chemotherapy and radiation, improving their quality of life and overall comfort. Additionally, the company is offering a free starter supply of ioRinse™ MR to oncology patients, addressing the cost burden of managing these oral mucositis symptoms.